Bruton tyrosine kinase inhibitors for chronic lymphocytic leukemia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437923/0/Bruton_tyrosine_kinase_inhibitors_for_chronic_lymphocytic_leukemia. Accessed 27 April 2024.
Bruton tyrosine kinase inhibitors for chronic lymphocytic leukemia. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437923/0/Bruton_tyrosine_kinase_inhibitors_for_chronic_lymphocytic_leukemia. Accessed April 27, 2024.
Bruton tyrosine kinase inhibitors for chronic lymphocytic leukemia. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/437923/0/Bruton_tyrosine_kinase_inhibitors_for_chronic_lymphocytic_leukemia
Bruton Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukemia [Internet]. In: Cochrane Abstracts. [cited 2024 April 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437923/0/Bruton_tyrosine_kinase_inhibitors_for_chronic_lymphocytic_leukemia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Bruton tyrosine kinase inhibitors for chronic lymphocytic leukemia
ID - 437923
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437923/0/Bruton_tyrosine_kinase_inhibitors_for_chronic_lymphocytic_leukemia
DB - Evidence Central
DP - Unbound Medicine
ER -